Novartis Income Statement

Health Care & Life Sciences » Pharmaceuticals | Novartis AG

Novartis AG | Income Statement

Fiscal year is January-December. All values CHF Millions.

2013

2014

2015

2016

2017

2018

Sales/Revenue

48,291

47,985

47,605

47,798

48,336

50,793

Cost of Goods Sold (COGS) incl. D&A

15,370

15,878

16,758

17,260

16,905

18,014

Gross Income

32,921

32,107

30,847

30,538

31,431

32,778

SG&A Expense

22,388

21,581

21,937

22,548

23,401

24,477

EBIT

11,639

9,585

8,211

9,040

9,540

Unusual Expense

304

754

510

331

1,283

2,017

Non Operating Income/Expense

762

795

864

196

691

397

Interest Expense

616

642

666

718

789

969

Pretax Income

9,463

9,478

7,576

7,008

7,767

7,239

Income Tax

1,389

1,414

1,065

1,102

1,276

1,195

Equity in Affiliates

555

1,756

256

693

1,091

6,301

Consolidated Net Income

8,630

9,820

6,767

6,599

7,582

12,345

Net Income

8,522

9,756

6,757

6,612

7,582

12,342

Net Income After Extraordinaries

8,537

10,165

3,610

6,612

7,582

12,342

Net Income Available to Common

8,506

9,346

17,123

6,612

7,582

12,342

EPS (Basic)

3.49

3.85

7.13

2.78

3.23

5.32

Basic Shares Outstanding

2,441

2,426

2,403

2,378

2,346

2,319

EPS (Diluted)

3.43

3.78

7.02

2.76

3.20

5.27

Diluted Shares Outstanding

2,479

2,470

2,438

2,400

2,371

2,344

EBITDA

15,437

15,631

14,616

13,482

14,168

14,782

Other Operating Expense

580

1,112

675

222

1,010

1,239

Non-Operating Interest Income

108

288

Minority Interest Expense

108

About Novartis

View Profile

Address	Lichtstrasse 35 Basel Basel-Stadt (Basle Town) 4056 Switzerland
Employees	-
Website	http://www.novartis.com
Updated	07/08/2019
Novartis AG is a holding company, which engages in the development, manufacture, and marketing of healthcare products. It operates through the following segments: Innovative Medicines, Alcon, Sandoz, and Corporate. The Innovative Medicines segment researches, develops, manufactures, distributes and sells patented pharmaceuticals, and is composed of two business units: Novartis Oncology and Novartis Pharmaceuticals.

Novartis AG | Income Statement

About Novartis

StatInvestor